US Patent

US9566259 — Fumarate ester dosage forms

Formulation · Assigned to Banner Life Sciences LLC · Expires 2035-02-27 · 9y remaining

Vulnerability score 30/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects pharmaceutical compositions, including oral controlled release forms, comprising fumarate esters suspended in liquid matrices.

USPTO Abstract

Described herein are pharmaceutical compositions comprising fumarate esters, methods for making the same, and methods for treating subjects in need thereof. In particular, oral controlled release pharmaceutical compositions comprising fumarate esters suspended in liquid matrices are described. One embodiment described herein is a pharmaceutical composition comprising fumarate esters suspended in a lipid or lipophilic liquid with enhanced bioavailability.

Drugs covered by this patent

Patent Metadata

Patent number
US9566259
Jurisdiction
US
Classification
Formulation
Expires
2035-02-27
Drug substance claim
No
Drug product claim
Yes
Assignee
Banner Life Sciences LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.